Teva's MS Drug Fails Ph3 Trial - Aug. 1, 2011

Having trouble viewing this email? View in Browser.

Monday, August 01, 2011  |   |   |   |  The ADAPT 2011 Congress Features 5 tracks and 7 short courses exploring the relationship between biomarkers and the promise of personalized therapy, how circulating tumor cells (CTCs) could better track the progression of cancer, and adaptive trials that bring targeted therapies to market. Discount registration by July 22. To learn more, visit www.ADAPTcongress.com. •  Teva Pharmaceutical Industries Limited (TEVA)'s Multiple Sclerosis Drug Fails Phase III Trial More... •  Cubist Pharmaceuticals, Inc. (CBST) Announces First Patient Dosed in Pivotal Global Phase 3 Trial of CXA-201 for Complicated Urinary Tract Infections More... •  AstraZeneca PLC (AZN) Announces U.S. Enrollment Opportunities for KODIAC Study to Investigate an Experimental Drug for Constipation from Opioids More... •  Amarin Corporation PLC (AMRN) Successfully Completes All Remaining Clinical Studies for AMR101 NDA More... •  BioAlliance Pharma Initiates the Clinical Batches Production of Livatag(R) (Doxorubicin Transdrug(TM)) for its Phase III Clinical Trial More... More Phase III News More Phase II News More Phase I News More Pre-Clinical News More Post-Approval News •  FDA Approves Bristol-Myers Squibb Canada (BMY)'s Self-injectable Form of RA Therapy Orencia More... •  Covidien (COV) Receives FDA Approval for Morphine Sulfate Oral Solution More... More Drug Approval News •  Pfizer Inc. (PFE) Says FDA Delays Prevnar Review For Three Months More... •  Protalix Biotherapeutics, Inc. (PLX) Reapplies for Gaucher's Drug FDA Approval and Reports Top-Line Results from the Company's Switchover Trial More... •  Ariad Pharmaceuticals, Inc. (ARIA) Announces That Its Partner, Merck & Co., Inc. (MRK), Has Submitted for Approval of Ridaforolimus, an Investigational mTOR Inhibitor, in the European Union More... •  Femta Pharmaceuticals Announces IND Filing of FM101, a Novel Monoclonal Antibody Targeting IL-6 with Potent Anti-Inflammatory Activity More... •  With Contracts and IND Application in Hand, Cellceutix Nears Clinical Trials for New Cancer Drug More... More BLA/NDA/ANDA News More IND News More MAA News •  Researchers Aim for "Direct Brain Control" of Prosthetic Arms, Rice University, University of Michigan, Drexel University, and University of Maryland Study More... •  Gum Disease Can Increase the Time it Takes to Become Pregnant, University of Western Australia Study More... •  Gene Variant Has Large Effect on Blacks' Asthma Risk, University of Chicago Study More... •  Low Blood Pressure During Dialysis Increases Risk of Clots, According to Stanford University Study More... •  New NeoGraft (TM) Device at Nouveau Jeunesse in Kennewick Improves Hair Transplants in Eastern Washington More... More General Clinical Research News 3rd Annual Partnerships in Clinical Trials Asia October 12-14, 2011 Grand Hyatt Shanghai The largest concentration of clinical decision makers specializing in clinical development, operations and outsourcing meet to provide you the opportunity to establish benchmarks, standards and next practices in the development and commercialization of products in a global marketplace. The agenda is filled with in-depth case studies on strategic partnering and effective outsourcing to ensure quality, control costs and accelerate cures to market. Please click here for more information. Advances in Drug-Diagnostic Co-Development • Understand the current regulatory environment for both diagnostics and drugs within the EU and the US and how these relate to their co-development. • Understand the biomarker discovery and validation process. • Using case studies discover how drugs and their companion diagnostics have already received approval in the US and EU. Click Here for More Information • Biotech Bay (Hayward, California) Anthera Pharmaceuticals, Inc. Director, Clinical Quality Assurance This position will be the lead and subject matter expert for GCP, playing a key role in ensuring GCP compliance at investigator sites and selected vendors, as well as reviewing clinical study reports, documents, and regulatory submissions for clarity and accuracy. • BioCapital (Germantown, Maryland) Intrexon Corporation Senior Research Scientist - DNA Vaccines The qualified candidate will work closely with a team of scientists in the Animal Sciences Division (ASD) to develop novel approaches to meet therapeutic needs of companion and farm animals. • Biotech Beach (San Diego, California) Ardea Biosciences, Inc. Clinical Program Manager The overall responsibility will be to manage one or more phase 2-3 studies for our lead development program in Gout. The successful candidate will manage CROs, clinical sites, liaise with Finance and Project Management. Etc. • BioCapital (Columbia, Maryland) Pfizer Inc. Director, Clinical Research and Development The purpose of the position is to provide medical and scientific expertise to design, plan and implement preclinical and clinical development programs for investigational and marketed drugs. Etc. • BioMidwest (Lake Forest, Illinois) Hospira, Inc. Associate Director/Director Biologics Drug Product Formulation and Process Development Will be responsible for identifying and developing suitable Drug Product formulations and manufacturing processes for Hospira's growing portfolio of Global Biologics compounds. Etc. • Get Noticed! Add your resume to the BioSpace Career Center! • See more than 5,000 job postings in the BioSpace Career Center! Biotech Beach Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Southern California region. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • Biotech Beach Career Fair, San Diego, CA September 22, 2011 • BioMidwest Career Fair, Chicago, IL October 4, 2011 • Pharm Country Career Fair, Bridgewater, NJ October 5, 2011 • Biotech Bay Career Fair, Burlingame, CA October 11, 2011 • Bio NC Career Fair, Durham, NC October 20, 2011 • BioCapital Beach Career Fair, Bethesda, MD November 1, 2011 • Genetown Career Fair, Cambridge, MA November 7, 2011 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services •  Vermillion Announces Notice of Allowance for Peripheral Artery Disease (PAD) Patent More... More Patent News •  Fera Pharmaceuticals Launches Four Ophthalmic Ointments More... More Drug Product News Hot Company Nektar Therapeutics 490 Discovery Drive Huntsville, Alabama 35806 U.S.A. Phone: 256-533-4201 Fax: 256-533-4805 Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its proprietary polymer conjugation technology platform. Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship ClinicaSpace 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 ClinicaSpace 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the ClinicaSpace News Beat Team. Editor & Publisher: Rosemary Do Editorial & Production Staff: Lana Ho, Suvarna Sheth, Matt Thwin, Maysa Darwish ClinicaSpace.com - Clinical Trials. Clinical Research. Community. • ClinicaSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2011 ClinicaSpace http://www.clinicaspace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from ClinicaSpace.com e-mail at any time by managing your account here.